Pharmaceutical major Wockhardt has bought out Rhein Biotech GmbH from their 50:50 joint venture, Wockhardt Rhein Biopharm, for an undisclosed sum.
Wockhardt will continue to hold a co-exclusive licence on Rhein
Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Pharmaceutical major Wockhardt has bought out Rhein Biotech GmbH from their 50:50 joint venture, Wockhardt Rhein Biopharm, for an undisclosed sum.
Wockhardt will continue to hold a co-exclusive licence on Rhein
First Published: Mar 27 2002 | 12:00 AM IST